The global stem cell therapy market size is expected to reach USD 900.08 million by 2030 according to a new study by Polaris Market Research. The report “Stem Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Allogeneic, Autologous); By Cell Source; By Therapeutic Application; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing prevalence of chronic disorders, increasing GMP certification approvals for cell therapy production with higher spending in medical research, and the growing number of clinical studies related to stem cell therapies are driving the market.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/stem-cell-therapy-market/request-for-sample
Increasing collaboration activities by market players are expected to drive the growth of the global market. For instance, in May 2018, Procella Therapeutics and Smartwise collaborated with AstraZeneca Pharmaceuticals to develop stem cell therapies in cardiovascular diseases using Procella Therapeutics’ stem cell technology.
COVID-19 has opened up new avenues for stem cell therapy. For Covid-19 patients, several stem cell-based regenerative medicine therapy clinical trials were conducted. Clinical trials are recognized as indispensable components of the pharmaceutical industry and the best hope for patients suffering from diseases.
Stem Cell Therapy Market Report Highlights
Polaris Market Research has segmented the stem cell therapy market report based on type, cell source, therapeutic application, and regions:
Stem Cell Therapy, Type Outlook (Revenue - USD Million, 2018 - 2030)
Stem Cell Therapy, Cell Source Outlook (Revenue - USD Million, 2018 - 2030)
Stem Cell Therapy, Therapeutic Application Outlook (Revenue - USD Million, 2018 - 2030)
Stem Cell Therapy, Regional Outlook (Revenue - USD Million, 2018 - 2030)